Novel agents before and after stem cell transplantation for myeloma
12 Apr 2016
Novel agents before and after stem cell transplantation for myeloma
Immunology highlights from the ITOC-3 conference
EBMT 2016 Highlights: Expert discussion
Novel technologies for understanding the repertoire of tumour infiltrating T cells in cancer
Targeting AFP in hepatocellular cancer
Combination of viroimmunotherapy with checkpoint inhibitors
Is PD-L1 really a predictive biomarker?
Patient perspective on immunotherapy and the ITOC-3 conference
Hypoxia and its impact on the immune system
The role of microRNAs in modulation of the immune escape of tumors
Reprogramming the cancer microenvironment with vaccine-based therapy
Biomarkers in t-cell therapy trials